User profiles for Richard M Cubbon

Richard Cubbon

Associate Professor of Cardiology, The University of Leeds
Verified email at leeds.ac.uk
Cited by 9846

Piezo1 integration of vascular architecture with physiological force

…, J Bilton, H Imrie, P Ajuh, TN Dear, RM Cubbon… - Nature, 2014 - nature.com
The mechanisms by which physical forces regulate endothelial cells to determine the
complexities of vascular structure and function are enigmatic 1 , 2 , 3 , 4 , 5 . Studies of sensory …

Association analyses based on false discovery rate implicate new loci for coronary artery disease

…, JC Chambers, R Clarke, CNA Palmer, RM Cubbon… - Nature …, 2017 - nature.com
Genome-wide association studies (GWAS) in coronary artery disease (CAD) had identified
66 loci at'genome-wide significance'(P< 5× 10− 8) at the time of this analysis, but a much …

Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study

…, GR Law, S Pavitt, JH Barth, RM Cubbon… - Journal of the American …, 2016 - jacc.org
Background : Patients with chronic heart failure (HF) secondary to left ventricular systolic
dysfunction (LVSD) are frequently deficient in vitamin D. Low vitamin D levels are associated …

[HTML][HTML] Piezo1 channels sense whole body physical activity to reset cardiovascular homeostasis and enhance performance

…, NY Yuldasheva, MJ Ludlow, RM Cubbon… - Nature …, 2017 - nature.com
Mammalian biology adapts to physical activity but the molecular mechanisms sensing the
activity remain enigmatic. Recent studies have revealed how Piezo1 protein senses …

Orai1 and CRAC Channel Dependence of VEGF-Activated Ca2+ Entry and Endothelial Tube Formation

J Li, RM Cubbon, LA Wilson, MS Amer… - Circulation …, 2011 - Am Heart Assoc
Rationale: Orai1 and the associated calcium release-activated calcium (CRAC) channel were
discovered in the immune system. Existence also in endothelial cells has been suggested, …

[HTML][HTML] Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study

M Pujades-Rodriguez, AW Morgan, RM Cubbon… - PLoS …, 2020 - journals.plos.org
Background Glucocorticoids are widely used to reduce disease activity and inflammation in
patients with a range of immune-mediated inflammatory diseases. It is uncertain whether or …

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

RM Cubbon, B Adams, A Rajwani… - Diabetes and …, 2013 - journals.sagepub.com
Background: It is unclear whether diabetes mellitus (DM) is an adverse prognostic factor in
chronic heart failure (CHF) of ischaemic and non-ischaemic aetiology managed with …

Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras

RM Cubbon, CP Gale, LC Kearney… - Circulation: Heart …, 2011 - Am Heart Assoc
Background— Therapies for patients with chronic heart failure caused by left ventricular
systolic dysfunction have advanced substantially over recent decades. The cumulative effect of …

Nox2 NADPH oxidase has a critical role in insulin resistance–related endothelial cell dysfunction

…, H Imrie, RM Cubbon, N Yuldasheva, M Gage… - Diabetes, 2013 - Am Diabetes Assoc
Insulin resistance is characterized by excessive endothelial cell generation of potentially
cytotoxic concentrations of reactive oxygen species. We examined the role of NADPH oxidase (…

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003

RM Cubbon, SB Wheatcroft, PJ Grant… - European heart …, 2007 - academic.oup.com
Aims Over the last decade, advances in treatment for patients sustaining an acute myocardial
infarction (AMI) have reduced mortality rates. We aimed to assess whether patients with …